EUVIMEDEUVIMED entdecken
Crossref

Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning

Abida, Abdullah R Alzahrani, Hayaa M Alhuthali, Afnan Alkathiri, Ruba Omar M Almaghrabi, Jawaher Mohammad Alshehri, Syed Mohammed Basheeruddin Asdaq, Mohd Imran

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02532-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Abida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, 91911, Rafha, Saudi Arabia. Hauptthemen laut MEDLINE: Pheochromocytoma, Precision Medicine, Machine Learning, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pheochromocytomas and paragangliomas (PCCs/PGLs) are uncommon neuroendocrine tumors with a significant genetic tendency. Approximately 35-40% of these tumors are associated with genetic factors. The present study performed a thorough analysis using publicly accessible genetic and clinical data from the Cancer Genome Atlas (TCGA) to examine the involvement of six genes, namely GBP1, KIF13B, GPT, CSDE1, CEP164, and CLCA1, in the development of PCCs/PGLs. By employing multi-omics data, this study investigates the relationship between mutational patterns and the prognosis of tumors, focusing on the possibility of tailoring treatment methods to individual patients. The study utilizes Mutect2 to detect somatic mutations with high confidence in whole-exome sequencing data from PCCG samples. The study uncovers mild effects on protein function caused by particular mutations, including GBP1 (p.Cys12Tyr), KIF13B (p.Arg847Gly), and GPT (p.Gln50Arg). A random forest classifier uses mutational profiles to predict potential drug recommendations, proposing a focused therapy strategy. This study thoroughly analyzes the genetic mutations found in PCCs/PGLs, highlighting the significance of precision medicine in developing specific treatments for these uncommon types of cancer. This study aims to improve the understanding of the development of tumors and identify personalized treatment approaches by combining genetic data with machine learning analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaPrecision MedicineMachine LearningAdrenal Gland NeoplasmsParagangliomaHumansMutationExome SequencingGenetic Testing

Stichwörter der Autor:innen

Genetic mutationsMachine learningParagangliomaPersonalized medicinePheochromocytomaPrecision oncology

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, 91911, Rafha, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Al-Abidiyah, P.O. Box 13578, 21955, Mecca, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
  • Laboratory Medicine Department, Faculty of Applied Medical Sciences, Al-Baha University, 65431, Albaha, Saudi Arabia.
  • Optometry Department, Faculty of Applied Medical Sciences, Al-Baha University, 65431, Al-Baha, Saudi Arabia.
  • Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, 13713, Riyadh, Saudi Arabia.

Zitieren

APA

Abida, Alzahrani, A. R., Alhuthali, H. M., Alkathiri, A., Almaghrabi, R. O. M., Alshehri, J. M., Asdaq, S. M. B., & Imran, M. (2024). Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning. Medical Oncology. https://doi.org/10.1007/s12032-024-02532-0

Vancouver

Abida, Alzahrani AR, Alhuthali HM, Alkathiri A, Almaghrabi ROM, Alshehri JM, et al. Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning. Medical Oncology. 2024. doi:10.1007/s12032-024-02532-0

BibTeX
@article{Abida2024,
  author = {Abida and Alzahrani, Abdullah R and Alhuthali, Hayaa M and Alkathiri, Afnan and Almaghrabi, Ruba Omar M and Alshehri, Jawaher Mohammad and Asdaq, Syed Mohammed Basheeruddin and Imran, Mohd},
  title = {Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02532-0}
}
Kostenlos starten →